quinazolines has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grekhnev, DA; Kaznacheyeva, EV; Kruchinina, AA; Vigont, VA | 1 |
| Ahlijanian, M; Bezprozvanny, I; Chen, X; Chesworth, R; Diggins, L; Glushankova, L; Hrdlicka, L; Kaznacheyeva, E; Koenig, G; Mahoney, M; Mozhayeva, GN; Shapiro, G; Shih, HP; Singh, C; Vigont, V; Wu, J; Wu, Q; Zimina, O | 1 |
1 review(s) available for quinazolines and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies.
Topics: Humans; Huntingtin Protein; Huntington Disease; Neurons; Phenyl Ethers; Quinazolines | 2022 |
1 other study(ies) available for quinazolines and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.
Topics: Animals; Apoptosis; Calcium; Cells, Cultured; Disease Models, Animal; Drosophila; Fura-2; Glutamic Acid; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurons; NF-kappa B; Nuclear Proteins; Phenyl Ethers; Quinazolines; RNA Interference; RNA, Small Interfering; TRPC Cation Channels | 2011 |